X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2022/09/29/2525541/0/en/TearClear-Announces-Positive-Topline-Results-from-CLEAR-Phase-3-Study-for-the-Treatment-of-Glaucoma-with-TC-002-latanoprost-ophthalmic-solution-0-005.html
https://www.globenewswire.com/news-release/2022/02/07/2379715/0/en/TearClear-announces-the-successful-initiation-of-its-TC-002-Latanoprost-Ophthalmic-Solution-Phase-3-trial.html